Kumar Rakhi (CIK 1856296) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-22). Recent activity: Buy NPCE (989 shares), Buy NPCE (2,890 shares), Buy NPCE (1,153 shares), Buy NPCE (904 shares), Buy NPCE (1,509 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | NeuroPace Inc (NPCE) | Director | Buy | 989 | $15,458 |
| 2026-06-05 | NeuroPace Inc (NPCE) | Director | Buy | 2,890 | $0 |
| 2026-03-23 | NeuroPace Inc (NPCE) | Director | Buy | 1,153 | $14,989 |
| 2025-12-23 | NeuroPace Inc (NPCE) | Director | Buy | 904 | $14,997 |
| 2025-09-22 | NeuroPace Inc (NPCE) | Director | Buy | 1,509 | $14,999 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 3,340 | $14,997 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,541 | $14,994 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,454 | $14,991 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,136 | $14,995 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,984 | $14,999 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 2,152 | $14,999 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,300 | $14,989 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,247 | $14,989 |
| 2025-06-24 | NeuroPace Inc (NPCE) | Director | Buy | 1,440 | $14,990 |
| 2025-02-24 | Roivant Sciences Ltd. (ROIV) | Chief Accounting Officer | Sell | 958 | $10,270 |
| 2025-02-18 | Roivant Sciences Ltd. (ROIV) | Chief Accounting Officer | Buy | 187,500 | $721,875 |
| 2025-02-18 | Roivant Sciences Ltd. (ROIV) | Chief Accounting Officer | Sell | 227,500 | $2.4M |
| 2025-01-22 | Roivant Sciences Ltd. (ROIV) | Chief Accounting Officer | Sell | 1,057 | $11,786 |
Source: SEC Form 4 filings · as of 2026-06-22